A

ABCL

ABCL

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
15%Bearish
Buy/Sell Ratio100% buys
BearishBullish
ABCL Live QuoteReal-time
$10.47
$1.77(-14.46%)1M
Day Range$10.38 – $11.29
Open$11.20
Previous Close$11.02
Volume2.50M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$3.60B
P/E Ratio (TTM)24.5
Forward P/E27.6
EPS (TTM)$-0.48
Price to Book3.4
Dividend Yield0.65%
Beta (Volatility)1.59
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $10.47 (63%)
Low: $2.75High: $15.02
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$18.69-87.5% upside

Insider Buys

2

$1.64M

Insider Sales

0

$0

Total Volume

$1.64M

13 transactions

Net Activity

+$1.64M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
95CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Minor cluster buying: 2 unique insiders purchased shares.
  • •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
  • •High accumulation: total purchase value exceeds $1M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

1 buys11 sells

$31582.19B total

B
2

Booth Andrew

CFO

1 buys0 sells

$97K total

Trading History
ABCL insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 13, 2026

1 weeks ago

Booth Andrew

CFO

CFO
Buy8.6K$11.33$97K

Aug 24, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.49M$53613.00$79.97B

Aug 18, 2026

3 months ago

Multiple Insiders

3 Insiders

Insider
Buy147.2K$10.50$1.55M

Aug 18, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell256.0K$10000.00$2.56B

Aug 12, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell1.44M$46387.00$66.71B

Aug 14, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell613.8K$37200.00$22.83B

May 14, 2026

6 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell246.0K$20000.00$4.92B

Feb 27, 2026

8 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell56.13M$38000.00$2133.10B

Feb 26, 2026

8 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell56.10M$177457.00$9954.65B

Nov 26, 2025

11 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell226.0K$50000.00$11.30B

Mar 11, 2025

20 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell56.14M$343631.00$19292.70B

Mar 10, 2025

20 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell176.0K$25000.00$4.40B

Mar 6, 2025

20 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell151.0K$60000.00$9.06B
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
ABCL Buy Conviction100%
Industry Rank#475 of 570
Volume Contribution0.0%
Total Industry Activity$16.52B

ABCL has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%. ABCL ranks #475 in insider activity out of 570 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for ABCL

Over the last 90 days, corporate insiders at ABCL (ABCL) engaged in a total of 13 transactions reported via SEC Form 4 filings. Among these, 2 were open-market purchases and 0 were sales. The total volume of insider trading reached $1.64M.

The net insider activity for ABCL shows a net buying bias of $1.64M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 56.14M shares valued at $19292.70B on Mar 11, 2025.

Live Market News & Developments
Aggregated real-time headlines for ABCL (ABCL)
6 updates

ABCL Stock Surges 121% in 3 Months: Here's What You Need to Know

Yahoo Finance59d ago

AbCellera Biologics (ABCL) Stock Looks Reasonable Following Its 221% Run

Simply Wall StYesterday

ABCL - AbCellera Biologics Inc Stock Price and Quote

Finviz176d ago

Hot-Flash Drug Trial Result Sends AbCellera Up as Much as 41%

Bloomberg.com102d ago

Jefferies reiterates Buy on AbCellera stock, $21 target on VMS therapy

Investing.com3d ago

AbCellera Biologics (ABCL) Stock Sees Fair Value Lift After Clinical Data And Jazz Deal

Yahoo Finance101d ago

FAQs About ABCL Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for ABCL.

Based on SEC Form 4 disclosures, the Insider Confidence Score for ABCL is currently 95/100, which reflects a strong accumulation bias. This calculation accounts for a total of 2 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for ABCL is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.